Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate

Detalles Bibliográficos
Autores principales: Tang, Thao, Le, Quy, Castro, Sommer, Pardo, Laura, McKay, Cyd Nourigat, Perkins, LaKeisha, Smith, Jenny, Kirkey, Danielle, Abrahams, Cristina, Bedard, Kristin, Molina, Arturo, Brodersen, Lisa Eidenshinck, Loken, Michael R., Tarlock, Katherine, Meshinchi, Soheil, Loeb, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701621/
https://www.ncbi.nlm.nih.gov/pubmed/36149945
http://dx.doi.org/10.1182/bloodadvances.2022008503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701621/
https://www.ncbi.nlm.nih.gov/pubmed/36149945
http://dx.doi.org/10.1182/bloodadvances.2022008503

Ejemplares similares